Childhood asthma drug linked to dozens of suicides and frightening hallucinations of 'red-eyed demons' is STILL being prescribed to 12m Americans each year - despite FDA warning in 2020
Nearly two years after the FDA added a black box warning to Singulair, millions of Americans continue to take the drug. Doctors are urging patients to be aware of the risks. (Source: the Mail online | Health)
Source: the Mail online | Health - January 9, 2024 Category: Consumer Health News Source Type: news
Young asthma-focused drug developer in billion-dollar deal with GSK
The potential buyout is one of a handful to emerge during this week's J.P. Morgan Healthcare Conference in San Francisco. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 9, 2024 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news
Mind over asthma | Science Signaling
JAK1 in the vagal sensory nerves that innervate lungs suppresses allergic inflammation and asthma. (Source: Signal Transduction Knowledge Environment)
Source: Signal Transduction Knowledge Environment - January 9, 2024 Category: Science Source Type: news
F.D.A. Warned of Mental Side Effects from Asthma Drug, Singulair. Few Were Told.
Singulair, now a generic, is still used by millions of people in the United States even after thousands of patients and dozens of studies have described harm. (Source: NYT Health)
Source: NYT Health - January 9, 2024 Category: Consumer Health News Authors: Christina Jewett and Benjamin Mueller Tags: Suicides and Suicide Attempts Asthma Drugs (Pharmaceuticals) Mental Health and Disorders Allergies Obsessive-Compulsive Disorder Food and Drug Administration Merck & Company Inc World Health Organization United States Singulair m Source Type: news
GSK agrees to buy respiratory medicine specialist Aiolos Bio for $1.4bn
UK pharma group hopes acquisition of three-month start-up will broaden its range of asthma treatments (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - January 9, 2024 Category: Pharmaceuticals Source Type: news
GSK to Buy Asthma Drug Developer Aiolos for Up to $1.4 Billion
(Source: Reuters: Health)
Source: Reuters: Health - January 9, 2024 Category: Consumer Health News Source Type: news
GSK Buys Asthma-Focused Aiolos
GSK said it bought biopharmaceutical company Aiolos Bio for an upfront consideration of $1.0 billion and the potential for an additional $400 million, the latest in a string of pharmaceutical majors buying fast-growing biotechs to restock their pipelines. The British pharmaceutical giant said…#gsk #aiolosbio (Source: Reuters: Health)
Source: Reuters: Health - January 9, 2024 Category: Consumer Health News Source Type: news
Using AI to identify high risk patients with asthma and COPD
A new Yale study shows that deep learning can improve detection of patients with these diseases who are at increased risk for multiple hospitalizations. (Source: Yale Science and Health News)
Source: Yale Science and Health News - January 8, 2024 Category: Universities & Medical Training Source Type: news
Could Inhaling a Statin Help Ease Asthma, COPD?
FRIDAY, Jan. 5, 2024 -- Drugs already used by millions to lower cholesterol might someday have a new role: Relieving asthma and COPD.
That ' s the hope of a new line of research underway at the University of California, Davis.
A study funded by the... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 5, 2024 Category: General Medicine Source Type: news
In Focus: Be proactive in respiratory care
What should our priorities be for respiratory care in general practice? Aleksandra Gawlik-Lipinski shares her personal views with Nursing in Practice editor Carolyn Scott Aleksandra Gawlik-Lipinski, a respiratory nurse specialist working in general practice in south London, believes respiratory care is ‘falling behind’ other specialties in the UK. Here, she tells Nursing in Practice that... Read moreThe post In Focus: Be proactive in respiratory care appeared first on Nursing in Practice. (Source: Nursing in Practice)
Source: Nursing in Practice - January 4, 2024 Category: Nursing Authors: Carolyn Scott Tags: Respiratory asthma breathlessness COPD spirometry Source Type: news
New Medicaid Rebate Rule Causes Problems For Asthma Patients On Flovent
Due to the convoluted drug pricing and reimbursement system, the authorized generic asthma med Flovent won ’t be as broadly covered by PBMs as the original brand was. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 3, 2024 Category: Pharmaceuticals Authors: Joshua Cohen, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & standard Source Type: news
Why GSK's Flovent asthma inhaler is being discontinued in 2024 : Shots - Health News
A popular asthma inhaler is leaving pharmacy shelves. Here's what you need to know Some asthma patients may start out the new year scrambling for their go-to inhaler – at least that's the concern as Flovent, a popular drug, leaves store shelves starting in January. Earlier this year, drugmaker GSK…#flovent #gsk #kennymendez (Source: Reuters: Health)
Source: Reuters: Health - December 30, 2023 Category: Consumer Health News Source Type: news
Asthma Sufferers Brace for'Huge Shock to the System '
An inhaler commonly used by people with asthma has just a few days left on drugstore shelves. Fast Company reports that as of Monday, Flovent will be officially discontinued in US pharmacies, though manufacturer GSK says an authorized generic version will take its place. In a November statement ,…#gsk #prasco #floventhfa #floventdiskus #flovent #robyncohen #bostonmedicalcenter #aap #medicaid #fastcompany (Source: Reuters: Health)
Source: Reuters: Health - December 30, 2023 Category: Consumer Health News Source Type: news
A popular asthma inhaler will be discontinued in January. Here's what to know
Flovent, a popular steroid inhaler used to treat and control asthma symptoms in children and adults, is being discontinued next week as its manufacturer prepares to roll out a generic version of the medication. Starting on Jan. 1, 2024, GlaxoSmithKline will stop manufacturing Flovent HFA and…#floventhfa #floventdiskus #gsk #flovent #medicaid #rescueplanact #aap #christophermoermann (Source: Reuters: Health)
Source: Reuters: Health - December 30, 2023 Category: Consumer Health News Source Type: news
How Lowering The Price of a Common Asthma Drug Made it Harder to Get
Earlier this year, parents trying to fill their children’s asthma prescriptions at pharmacies around the country got a jolt: The medicine was no longer covered. Soon, it would disappear from the market. (Source: Reuters: Health)
Source: Reuters: Health - December 29, 2023 Category: Consumer Health News Source Type: news
